Healthcare & Pharmaceuticals

From patient care to innovation, we're supporting the future of healthcare.

Overview

About 10% of Australia's GDP is spent on health. What are we getting for that? We get more than just a trip to the doctor, that's for sure. Modern healthcare encompasses extraordinary technical advances, commercialisation, patents, trade marks and other IP, and a highly regulated pharmaceutical sector.

There's innovation too in the way health services are developed and delivered, from research and health precincts through to healthcare infrastructure such as hospitals or aged care homes which integrate the latest technology with old-fashioned care and compassion. For those running a healthcare facility, there are also medical negligence and disciplinary proceedings. Underlying it all is the need to protect, manage and utilise vast amounts of sensitive data within strict privacy laws. And then there are the business issues: corporate governance, real estate acquisition, planning approvals, investments, and exit strategies.

We might not be able to solve physical headaches as easily as you can, but we know how to deal with the legal headaches – and even stop them from happening.

Our team to support you

Insights
Victorian employers get new requirements on psychosocial hazards
2 Oct 2025 | Article
Read Insights
Closing the hidden ownership gap: Australia's proposed reforms to derivative disclosure and tracing
2 Oct 2025 | Article
Read Insights
Australian patents update: Aristocrat finally prevails, in long-running patentability dispute over electronic gaming machines
30 Sep 2025 | Article
Read Insights
Faster IPOs on the horizon: ASIC launches two-year fast-track listing trial
30 Sep 2025 | Article
Read Insights
Australia’s 2035 Climate Commitment: a pragmatic path to net zero?
30 Sep 2025 | Article
Read Insights
Record $57.5m cartel penalty upheld as cartel enforcement increases
11 Sep 2025 | Article
Read Insights
Foreign investment in Australia in October – December 2024: key insights from the latest quarterly report
10 Sep 2025 | Article
Read Insights
Set-off on Award entitlements: The Federal Court has spoken
5 Sep 2025 | Article
Read Insights
Climate-related transition plan guidance – Treasury's consultation paper sets out recommended best practice
4 Sep 2025 | Article
Read Insights
The cost of whistleblower victimisation: TerraCom's $7.5 million penalty
28 Aug 2025 | Article
Read Insights
Australia patents update: Federal Court revisits best method knowledge requirement for divisional patents
26 Aug 2025 | Article
Read Insights
Indemnity cost orders: why the time period for a "reasonable" offer might be shorter than you think
26 Aug 2025 | Article
Read Insights